STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

KRYS KRYSTAL BIOTECH INCORPORATED StockScouter® Report

4

StockScouter® Score

KRYSTAL BIOTECH INCORPORATED, a mid cap company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Moving average analysis for KRYS suggests strong price movement over the medium term. Positive
  • Short-term relative price momentum exhibits meaningful strength. Postive

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • Two or more executives, directors or major shareholders sold a large number of shares recently. Very negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 60% done.
Low
High

Core Model Grades

C
F
N/A
C

Previous Ratings

5
5
3